In the present study, we demonstrated that MSC migration to HCC tumors can be effectively inhibited in the presence of TACE and ɣ-secretase inhibitors, which prevented the activation of EpCAM signaling event. This evidence concerns the gene EPCAM and hepatocellular carcinoma.